Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors

Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors

Abstract Background Immune-mediated pneumonitis has a high mortality rate; however, information regarding the related risk factors remains limited. This study aimed to analyze risk factors for pneumonitis, including smoking and lung metastasis (LM), in patients with extrapulmonary primary tumors. Me...

Full description

Bibliographic Details
Main Authors: Yasuki Uchida, Daisuke Kinose, Yukihiro Nagatani, Sachiko Tanaka-Mizuno, Hiroaki Nakagawa, Kentaro Fukunaga, Masafumi Yamaguchi, Yasutaka Nakano
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Cancer
Subjects:
Extrapulmonary tumor
Immune checkpoint inhibitors
Lung metastasis
Nivolumab
Pembrolizumab
Pneumonitis
Online Access:https://doi.org/10.1186/s12885-022-09642-w

Internet

https://doi.org/10.1186/s12885-022-09642-w

Similar Items